Clinical trial
Vaccination of Children Following Allogeneic Stem Cell Transplantation
NCT00169728 · Heinrich-Heine University, Duesseldorf, Other · Completed
Key facts
| NCT number | NCT00169728 |
|---|---|
| Title | Vaccination of Children Following Allogeneic Stem Cell Transplantation |
| Official title | Immunogenicity of the DTaP-IPV-HBV/Hib Combination Vaccine Infanrix Hexa and the Heptavalent Pneumococcal Conjugate Vaccine Prevenar in Pediatric Recipients of Allogeneic Haematopoietic Stem Cell Transplantation |
| Lead sponsor | Heinrich-Heine University, Duesseldorf, Other |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry GlaxoSmithKline |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Allogeneic Haematopoietic Stem Cell Transplantation |
| Intervention type | Biological |
| Interventions | DTaP-IPV-HBV/Hib combination vaccine, Infanrix hexa, heptavalent pneumococcal conjugate vaccine, Prevenar |
| Enrollment | 53 |
| Start date | Sep 1, 2003 |
| Primary completion | Jun 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 7, 2012 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: